
NHIA 2025 Pre-Conference Ask the Experts: One Year After the Implementation of USP Revisions - Live 2/26/2025
Includes a Live Web Event on 02/26/2025 at 12:00 PM (EST)
-
Register
- Prices available after logging in
One year after the implementation of the revised USP <797> standards, this session will provide an in-depth look at the impact of these changes on pharmacy operations, compliance, patient safety, and quality assurance practices. This session presents a unique opportunity to engage directly with industry leaders and experts in sterile compounding. During this interactive panel discussion, experts will address the most pressing challenges and concerns surrounding the revised guidelines, sharing real-world insights and strategies for navigating the evolving regulatory landscape. Attendees will gain valuable knowledge on how to optimize workflows, ensure ongoing compliance, integrate new technologies, and implement best practices to meet the revised standards.
Learning Objectives:
- Identify common Challenges and concerns related to sterile compounding practices and explore expert recommendations for overcoming them.
- Deepen understanding of the latest best practices through interactive discussion with experts in the field.
- Clarify complex issues through direct interaction with experts.

Gene Decaminada, RPh, BSPharm, FNHIA
Pharmacy Manager Home Infusion
Yale New Haven Health
Gene Decaminada is currently the Pharmacy Manager for the Home Infusion Program at Yale New Haven Health Services (YNHHS). NHIA Fellowship Award (2021); CPA mentor (2021, 2022) YNHHS Mentor (2022); NHIA Peer Review Member (2021); CPA Professional Pharmacy Performance Award (2021); BPS Sterile Compounding Council Member (term concluded 12/31/21); former NHIA National Standards and Sterile Compounding Education Committee member; PTCB Certificate Program instructor CT Community College (2021); CPA Sterile Compounding Conference Committee member; NHIA Sterile Compounding Practice Committee (SCPC) member; Vizient Home Infusion subcommittee member; and a selected member of the Institute for Excellence at YNHHS Lean-In Class of 2022.

Kevin Hansen
Premier Inc

Barbara Petroff, MS, RPh, FASHP, BCSCP, FNHIA, CAC, CSPP, IgCP
Principal
Shawler Petroff LLC
Barbara J. Petroff, MS, RPh, FASHP FNHIA, is currently Principal at Shawler Petroff LLC. In addition she is an accreditation surveyor for the Accreditation Commission for Health Care. She received her BS in pharmacy at Ohio State University and an MS in administration at Central Michigan University. She has worked in several pharmacy arenas including research, hospital, retail and home infusion. Petroff has served ASHP in many capacities. She also serves as Chair of the Sterile Compounding Practice Committee for the National Home Infusion Association. She was awarded certification in sterile compounding (BCSCP) from the Board of Pharmaceutical Specialties.
NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.
Barbara Petroff has no relevant financial relationships with ineligible companies to disclose.

Glen Gard
Option Care Health

Lilit Smith, PharmD, MBA, BCSCP
Home Infusion Manager
Baptist Health South Florida
Lilit Smith Pharm.D., MBA, BCSCP serves as the Home Infusion Manager at Baptist Health South Florida. She received her Doctor of Pharmacy in 2007 and MBA in 2015 both from the University of Connecticut. In 2019 she achieved Board Certification as a Sterile Compounding Pharmacist.
She recently opened the home infusion service line and continues to expand the operation. Prior to this Dr. Smith held the role of Manager for Compounding and Compliance. She worked with the 12 hospitals within the health system in standardizing cleanroom design, policy development, outsourcing oversight and staff training, competency and education.
NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.
Lilit Smith has no relevant financial relationships with ineligible companies to disclose.